The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Why This Tiny New Jersey Biotech Looks Like in 1986 June 11, 2017 Creative Peptides Shortened Their Supply Turnaround Time April 13, 2017 The Leukemia & Lymphoma Society Appoints As Chief Medical Officer March 16, 2017